CV Lattes
ORCID
Google Scholar Citations
Fundação Pio XII (FP). Hospital do Câncer de Barretos (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciências Biológicas from Universidade do Estado de Minas Gerais (2006), master's at Genetics from Universidade Federal de Uberlândia (2010) and doctorate at Oncologia from Fundação Pio XII (2016). He is currently parcial at Faculdade de Ciências da Saúde de Barretos Dr. Paulo Prata. Has experience in Morphology, focusing on Cytology and Celular Biology, acting on the following subjects: estresse oxidativo, diabetes, bioquimica, exercicio and gelatinases. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Gain-of-function mutations in the KRAS gene lead to constitutive protein activity, which is associated with tumorigenesis and tumor progression in pancreatic, colorectal, and lung cancer. The challenge in creating therapies against KRAS has extended for decades due to the structural complexity of this protein. However, after the discovery of druggable portions in some of the KRAS variants…
Antineoplastic drug development is based on the discovery of efficient molecules with lower cost and specific for the neoplastic cell target. In recent years, hybrid molecules' conceit has gained prominence, as they act synergistically, in reduced doses, and less likely to develop resistance, compared to the individual antineoplastic compounds. The screening of a new molecule can be perf…
| 1 / 1 | Ongoing grants |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All research grants and scholarships |
| Associated processes | |